JPWO2020262497A1 - - Google Patents

Info

Publication number
JPWO2020262497A1
JPWO2020262497A1 JP2021527709A JP2021527709A JPWO2020262497A1 JP WO2020262497 A1 JPWO2020262497 A1 JP WO2020262497A1 JP 2021527709 A JP2021527709 A JP 2021527709A JP 2021527709 A JP2021527709 A JP 2021527709A JP WO2020262497 A1 JPWO2020262497 A1 JP WO2020262497A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021527709A
Other languages
Japanese (ja)
Other versions
JP7572007B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2020262497A1 publication Critical patent/JPWO2020262497A1/ja
Application granted granted Critical
Publication of JP7572007B2 publication Critical patent/JP7572007B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2021527709A 2019-06-25 2020-06-24 ニコチンアミドモノヌクレオチド(nmn)およびニコチンアミドリボシド(nr)の新規用途 Active JP7572007B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019117642 2019-06-25
JP2019117642 2019-06-25
PCT/JP2020/024916 WO2020262497A1 (ja) 2019-06-25 2020-06-24 ニコチンアミドモノヌクレオチド(nmn)およびニコチンアミドリボシド(nr)の新規用途

Publications (2)

Publication Number Publication Date
JPWO2020262497A1 true JPWO2020262497A1 (https=) 2020-12-30
JP7572007B2 JP7572007B2 (ja) 2024-10-23

Family

ID=74060627

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021527709A Active JP7572007B2 (ja) 2019-06-25 2020-06-24 ニコチンアミドモノヌクレオチド(nmn)およびニコチンアミドリボシド(nr)の新規用途

Country Status (7)

Country Link
US (1) US20220370484A1 (https=)
EP (1) EP3991795B1 (https=)
JP (1) JP7572007B2 (https=)
CN (1) CN114007693B (https=)
ES (1) ES2989969T3 (https=)
PL (1) PL3991795T3 (https=)
WO (1) WO2020262497A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119792334A (zh) * 2025-02-25 2025-04-11 中国农业大学 组合物及其应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008542296A (ja) * 2005-05-25 2008-11-27 サートリス ファーマシューティカルズ, インコーポレイテッド サーチュイン活性化剤による眼障害の処置
US9844561B2 (en) * 2013-03-15 2017-12-19 Washington University Administration of nicotinamide mononucleotide in the treatment of disease
JP2018535956A (ja) * 2015-10-23 2018-12-06 ザ ジャクソン ラボラトリー 眼神経変性障害(例えば緑内障)の処置及び予防における使用のためのニコチンアミド
WO2020054795A1 (ja) * 2018-09-14 2020-03-19 めぐみ 田中 老化防止剤及び老化防止方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018100222A (ja) * 2015-04-20 2018-06-28 学校法人慶應義塾 角膜損傷の治療剤、改善剤または予防剤
US20170326161A1 (en) * 2015-12-10 2017-11-16 Imprimis Pharmaceuticals, Inc. Pharmaceutical formulations for treating skin disorders and methods for fabricating and using thereof
US10898738B2 (en) * 2016-09-13 2021-01-26 Megumi Tanaka Visual function printing agent, and method for improving visual functions
JP6831407B2 (ja) 2019-02-22 2021-02-17 能美防災株式会社 火災受信機

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008542296A (ja) * 2005-05-25 2008-11-27 サートリス ファーマシューティカルズ, インコーポレイテッド サーチュイン活性化剤による眼障害の処置
US9844561B2 (en) * 2013-03-15 2017-12-19 Washington University Administration of nicotinamide mononucleotide in the treatment of disease
JP2018535956A (ja) * 2015-10-23 2018-12-06 ザ ジャクソン ラボラトリー 眼神経変性障害(例えば緑内障)の処置及び予防における使用のためのニコチンアミド
WO2020054795A1 (ja) * 2018-09-14 2020-03-19 めぐみ 田中 老化防止剤及び老化防止方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MILLS, K.F. ET AL.: "Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decli", CELL METABOLISM, vol. 24, JPN6020026595, 2016, pages 795 - 806, ISSN: 0005343859 *

Also Published As

Publication number Publication date
JP7572007B2 (ja) 2024-10-23
EP3991795A1 (en) 2022-05-04
EP3991795A4 (en) 2023-07-19
CN114007693B (zh) 2024-07-12
EP3991795B1 (en) 2024-09-11
PL3991795T3 (pl) 2025-01-13
CN114007693A (zh) 2022-02-01
US20220370484A1 (en) 2022-11-24
WO2020262497A1 (ja) 2020-12-30
ES2989969T3 (es) 2024-11-28

Similar Documents

Publication Publication Date Title
BR112019017762A2 (https=)
BR112021017339A2 (https=)
BR112021018450A2 (https=)
BR112021017637A2 (https=)
BR112021017892A2 (https=)
BR112021017782A2 (https=)
BR112021016821A2 (https=)
BR112021017939A2 (https=)
BR112021017738A2 (https=)
BR112021016996A2 (https=)
BR112021008711A2 (https=)
BR112019016141A2 (https=)
BR112021017728A2 (https=)
AU2020104490A5 (https=)
BR112021013944A2 (https=)
BR112021018452A2 (https=)
BR112021017703A2 (https=)
BR112021018102A2 (https=)
BR112019016142A2 (https=)
BR112019016138A2 (https=)
BR112021017732A2 (https=)
BR112021017234A2 (https=)
BR112021017355A2 (https=)
BR112021018168A2 (https=)
BR112021018093A2 (https=)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20220216

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230523

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20230721

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20230818

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240611

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240719

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240910

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20241002

R150 Certificate of patent or registration of utility model

Ref document number: 7572007

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150